CD147 as a novel biomarker for predicting the prognosis and clinicopathological features of bladder cancer: a meta-analysis
Author:
Affiliation:
1. Xiangya Hospital, Central South University, Changsha, Hunan Province, China
2. Reproductive Department, Xiangya Hospital, Central South University, Changsha, Hunan Province, China
Publisher
Impact Journals, LLC
Subject
Oncology
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeting cancer-derived extracellular vesicles by combining CD147 inhibition with tissue factor pathway inhibitor for the management of urothelial cancer cells;Cell Communication and Signaling;2024-02-15
2. Cluster of differentiation 147 (CD147) as potential membrane protein biomarker for bladder cancer cells;Journal of Pharmaceutical and Biomedical Analysis;2023-11
3. CD147 Expression Is Associated with Tumor Proliferation in Bladder Cancer via GSDMD;BioMed Research International;2020-02-21
4. Identification of LCA-binding Glycans as a Novel Biomarker for Esophageal Cancer Metastasis using a Lectin Array-based Strategy;Journal of Cancer;2020
5. The Prognostic and Clinicopathologic Characteristics of OCT4 and Lung Cancer: A Meta-Analysis;Current Molecular Medicine;2019-04-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3